Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015

Egilman Alexander C.; Wallach Joshua D.; Ross Joseph S.; Dhruva Sanket S.

首页> 外文期刊>JAMA internal medicine >Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015

【24h】

Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015

机译：Medicare支出和潜在节省品牌药物，可用通用替代品被2个大型药房福利经理，2012年至2015年排除在外

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JAMA internal medicine 》 |2018年第4期| 共3页
作者
Egilman Alexander C.; Wallach Joshua D.; Ross Joseph S.; Dhruva Sanket S.;
展开▼
作者单位

Yale Univ Collaborat Res Integr &

Transparency New Haven CT USA;

Yale Univ Collaborat Res Integr &

Transparency New Haven CT USA;

Yale Univ Collaborat Res Integr &

Transparency New Haven CT USA;

Vet Affairs Connecticut Healthcare Syst Robert Wood Johnson Fdn Clin Scholars Program 333 Cedar;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学 ;
关键词

相似文献

外文文献
专利

1. Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015 [J] . Egilman Alexander C., Wallach Joshua D., Ross Joseph S., JAMA internal medicine . 2018 ,第4期

机译：Medicare支出和潜在节省品牌药物，可用通用替代品被2个大型药房福利经理，2012年至2015年排除在外
2. Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 [J] . Jennifer S. Haas Kathryn A. Phillips Eric P. Gerstenberger and Andrew C. Seger Annals of Internal Medicine . 2005 ,第11期

机译：用非专利药替代名牌药品的潜在节省：医疗支出专门小组调查，1997–2000年
3. Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing (vol 168, pg 436, 2016) [J] . Bai G., Sen A. P., Anderson G. F. Annals of Internal Medicine . 2018 ,第12期

机译：药房福利经理，品牌药物价格和患者成本分享（Vol 168，PG 436,2016）
4. The burden of Part D: Does the Medicare drug benefit affect the percentage of income senior citizens spend out-of-pocket? [D] . Kress, Marielle. 2010

机译：D部分的负担：Medicare药物福利是否会影响老年人自付费用的收入百分比？
5. Impacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit [O] . Steven Sheingold, Nguyen Xuan Nguyen 2014

机译：通用竞争和收益管理做法对处方药支出的影响：Medicare D部分收益的证据
6. Impacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit [O] . Steven Sheingold, Nguyen Nguyen 2014

机译：通用竞争与福利管理实践对处方药支出的影响：来自Medicare的Diply D益处

Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015

著录项

相似文献

相关主题

期刊订阅